Precision Pen cartridges (pack of 3)Subcutaneous (SQ)3 × 2 mg (0.67 mg/ml, 3 ml)
★ Growth Hormone Signalling★ Recovery & Sleep
CJC-1295 without DAC is a short-acting GHRH analogue researched for its effect on the body’s own growth hormone signalling. The interest is not simply in pushing hormone levels higher, but in understanding how natural pulsatile signalling relates to recovery, sleep and body composition.
Shipping Information
Shipping Information
Free Shipping
Decor Outdoor offers free regular shipping on all orders shipped to residential or commercial addresses within the contiguous United States. Orders are delivered Monday through Friday (excluding holidays).Drop Shipping
We are an online-only luxury furniture and lighting boutique, and do not have a warehouse. Consequently, all orders are drop shipped directly from our manufacturers to your door. If your order includes items from more than one manufacturer, you will receive multiple deliveries. Because we are dependent on the on-hand inventory of our manufacturing partners, some items listed on our site may not actually be available right away. Please call us at 888.784.4644 or via our contact form with any stocking questions and we'll get in touch with the appropriate manufacturer for answers, before you place your order.Ground Shipping
Small parcel items ship regular ground via delivery services such as FedEx, UPS or DHL. Orders typically take 2-3 business days to process and in-stock items will usually be delivered 3-5 days from the date that they ship (depending on origin and destination). If there is a delay, you will be notified by email. No signature is required for standard ground shipping, so you may want to make arrangements to have packages brought inside soon after delivery, if you are unable to receive it in person.
Storage & Handling
Follow the storage instructions on your product label and the information supplied with your batch. Storage and handling requirements vary by product and presentation.
CJC-1295 without DAC is designed to act on the growth hormone releasing hormone pathway. Unlike long-acting DAC versions, the no-DAC form is shorter acting and is generally discussed in the context of preserving a more pulse-like pattern of signalling. This Precision Pen cartridge is part of the PHI Bluezone Series.
Growth hormone signalling, recovery, sleep and body-composition research.
The PHI Perspective
Hormones are not a shortcut. The value is in understanding the pathway, the individual and the objective, then measuring rather than guessing.
For clinician-directed use only where permitted.
How It Works
As a GHRH analogue, CJC-1295 without DAC is designed to stimulate the pituitary growth hormone pathway. Its shorter duration distinguishes it from DAC-containing formulations.
What the Research SuggestsHuman research on GHRH analogues supports the underlying biology of growth hormone release, but evidence for this exact compounded presentation and broad performance outcomes is limited.
Evidence level: C. Mechanistically plausible with human GHRH-pathway data; product-specific performance evidence remains limited.
Storage & Handling
Keep refrigerated at 2–8°C. Do not freeze. Protect from light. Follow the batch-specific product label and handling instructions.
Active compound: CJC-1295 without DAC, a growth hormone releasing hormone analogue
Mechanism of ActionBinds to GHRH receptors in the pituitary and promotes endogenous growth hormone release. The no-DAC presentation is shorter acting than DAC-bound CJC-1295 and is intended to produce a briefer signalling window.
Clinical Evidence BaseThe GHRH pathway is well characterised in humans. Published evidence for CJC-related molecules shows stimulation of growth hormone signalling, but data for no-DAC compounded use in healthy adults and performance settings are limited.
Safety & PrecautionsPotential effects can relate to increased GH and IGF-1 signalling and may include fluid retention, headache, tingling, changes in glucose handling and injection-site reactions. Long-term safety for performance or longevity use is not established.
ContraindicationsPregnancy and breastfeeding; active malignancy; known hypersensitivity. Specialist review is appropriate where disorders of glucose metabolism, pituitary disease or other endocrine conditions are present.
Literature & ReferencesUse a current clinical literature review on GHRH analogues and CJC-related compounds. Confirm exact molecule identity, no-DAC specification and product-specific references before publication.
